On May 9, 2024, Eli Lilly and Company announced that it held its annual general meeting of shareholders on May 6, 2024, and declared voting results. Accordingly, a shareholder proposal from Trinity Health, requesting to establish and report on a process by which the impact of extended patent exclusivities on product access would be considered in deciding whether to apply for secondary and tertiary patents was not approved.
Market Closed -
Other stock markets
|
After market 20:00:00 | |||
807.4 USD | -0.13% | 806.5 | -0.12% |
05-24 | Health Care Down on Rotation Out of Sector - Health Care Roundup | DJ |
05-24 | News Highlights : Top Company News of the Day - Friday at 5 PM ET | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.51% | 728B | |
+33.05% | 603B | |
-6.23% | 360B | |
+18.78% | 332B | |
+1.35% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.19% | 164B | |
-0.27% | 122B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Declaration of Voting Results by Eli Lilly and Company